We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.6B
AUM Growth
+$2.17B
Cap. Flow
-$81M
Cap. Flow %
-0.49%
Top 10 Hldgs %
31.47%
Holding
166
New
39
Increased
28
Reduced
33
Closed
30

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$366M
2
XLNX
Xilinx Inc
XLNX
+$332M
3
RTX icon
RTX Corp
RTX
+$299M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$289M
5
AVGO icon
Broadcom
AVGO
+$243M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$498M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$299M
3
ABBV icon
AbbVie
ABBV
+$298M
4
PANW icon
Palo Alto Networks
PANW
+$217M
5
BMY icon
Bristol-Myers Squibb
BMY
+$215M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Communication Services 13.23%
3 Financials 10.05%
4 Technology 9.85%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
26
Fate Therapeutics
FATE
$326M
$273M 1.64%
3,000,000
-125,000
-4% -$7.76M
AVGO icon
27
Broadcom
AVGO
$2.04T
$273M 1.64%
+6,229,950
New +$243M
BX icon
28
Blackstone
BX
$110B
$252M 1.52%
3,891,886
+62,550
+2% +$3.64M
EXEL icon
29
Exelixis
EXEL
$13.4B
$221M 1.33%
11,000,000
+250,000
+2% +$5.23M
EDU icon
30
New Oriental
EDU
$8.98B
$214M 1.29%
1,154,300
-214,478
-16% -$36.1M
WORK
31
DELISTED
Slack Technologies, Inc.
WORK
$207M 1.25%
+4,912,300
New +$166M
WTW icon
32
Willis Towers Watson
WTW
$32B
$203M 1.22%
962,500
+912,500
+1,825% +$188M
IPHI
33
DELISTED
INPHI CORPORATION
IPHI
$199M 1.2%
+1,239,800
New +$174M
BABA icon
34
Alibaba
BABA
$308B
$199M 1.19%
853,300
+240,715
+39% +$66.8M
MRTX
35
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$192M 1.16%
875,000
– –
HLT icon
36
Hilton Worldwide
HLT
$71.5B
$183M 1.1%
1,640,437
+94,560
+6% +$9.37M
QGEN icon
37
Qiagen
QGEN
$8.72B
$172M 1.04%
+3,071,316
New +$164M
TRU icon
38
TransUnion
TRU
$15.3B
$172M 1.03%
1,734,082
-80,050
-4% -$7.33M
ASND icon
39
Ascendis Pharma A/S
ASND
$16.8B
$167M 1%
1,000,000
-250,000
-20% -$41.3M
HWM icon
40
Howmet Aerospace
HWM
$112B
$140M 0.84%
4,891,479
-2,318,909
-32% -$51.6M
MXIM
41
DELISTED
Maxim Integrated Products
MXIM
$137M 0.82%
1,542,400
+312,400
+25% +$24.6M
APLS
42
DELISTED
Apellis Pharmaceuticals
APLS
$130M 0.78%
2,275,000
– –
ABBV icon
43
AbbVie
ABBV
$435B
$123M 0.74%
1,150,000
-3,100,000
-73% -$298M
AMRS
44
DELISTED
Amyris Inc.
AMRS
$108M 0.65%
17,500,000
+3,500,000
+25% +$11.2M
SRPT icon
45
Sarepta Therapeutics
SRPT
$1.77B
$102M 0.62%
600,000
– –
PCG icon
46
PG&E
PCG
$38.5B
$90.9M 0.55%
7,292,042
– –
SAGE
47
DELISTED
Sage Therapeutics
SAGE
$90.8M 0.55%
1,050,000
– –
PLYA
48
DELISTED
Playa Hotels & Resorts
PLYA
$89.2M 0.54%
14,994,867
-15,612,063
-51% -$72.4M
LU icon
49
Lufax Holding
LU
$1.3B
$76.1M 0.46%
+1,339,438
New +$80.2M
ENTA icon
50
Enanta Pharmaceuticals
ENTA
$400M
$74.7M 0.45%
1,775,000
– –
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Farallon Capital Management held 166 positions worth $16.6B, up 15% from $14.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Farallon Capital Management's Q4 2020 filing shows 39 new, 28 increased, 33 reduced and 30 closed positions. Its largest new stake was Aramark: 15,268,169 shares worth $424M. The largest sale was Immunomedics Inc, an estimated $498M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Communication Services and Financials.

  • Farallon Capital Management's largest Q4 2020 buy was Aramark: 15,268,169 shares worth $424M.
  • Farallon Capital Management added most to Willis Towers Watson in Q4 2020, an estimated $188M increase.
  • Farallon Capital Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $298M.
  • Farallon Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $498M.
  • Farallon Capital Management's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2020.
  • Farallon Capital Management opened 39 new positions and closed 30 in Q4 2020.
  • Farallon Capital Management's portfolio value rose 15% quarter-over-quarter to $16.6B.

Based on Farallon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.